BÜCHI Rotavapor R-300 Receives Design Awards
BÜCHI Rotavapor R-300 received the German Design Awards 2016, the RedDot Award 21, and the iF International Forum Design Award.
BÜCHI Labortechnik AG’s rotary evaporator Rotavapor R-300 received the German Design Awards 2016, the RedDot Award 21, and the iF International Forum Design Award. The User Interface I-300 and I-300 Pro for the R-300 received the iF Award in the category communication, BÜCHI said in an April 20, 2016 press announcement.
The rotary evaporator Rotavapor R-300 evaporates liquids for separation. I-300 and I-300 Pro are interfaces for the BUCHI Rotavapor R-300. Both are fully automated process controllers of all system components-attached on the rotary evaporator. The I-300 Pro offers the additional option of navigating the menu either by using the function buttons/push-wheel, the touchscreen functionality of the display, or both combined. The different modes (operating or processing) are visually separated by trough reversing the display colors.
Source: BÜCHI Labortechnik AG
How Smart Technology is Helping Reach Sustainability Goals in Drug Packaging
June 7th 2025Smart technologies, such as digital and laser printing, incorporated into manufacturing equipment are helping manufacturers align with sustainability goals, according to Sheikh Akbar Ali, general manager and head of Development and Technology for ACG Packaging Materials.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
